• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Video

Considerations in Treatment Selection for BCC

Author(s):

Laura Ferris, MD, PhD,Andrew Weinstein, MD, FAAD

Experts in dermatology comment on their considerations relating to treatment selection in their patients with basal cell carcinoma, highlighting the impact of cemipulab in this space.

Related Videos
Related Content
Neoadjuvant Intralesional 5-Fluorouracil Injection: Improved SCC Treatment in Older Patients
October 14th 2024

Neoadjuvant Intralesional 5-Fluorouracil Injection: Improved SCC Treatment in Older Patients

The Cutaneous Connection: Episode 27
July 22nd 2021

The Cutaneous Connection: Episode 27- Benzene Contamination Update

Q&A: Jeffrey Stricker, DO, MBA, Discusses Study on Image-Guided SRT in Non-Melanoma Skin Cancers
September 4th 2024

Q&A: Jeffrey Stricker, DO, MBA, Discusses Study on Image-Guided SRT in Non-Melanoma Skin Cancers

The Cutaneous Connection
May 27th 2021

The Cutaneous Connection: Episode 24- Benzene Found in Multiple Sunscreen Products

Q&A: DaRT Guidelines for Nonmelanoma Skin Cancer Care
August 2nd 2024

Q&A: DaRT Guidelines for Nonmelanoma Skin Cancer Care

Deep Histological Margins Do Not Increase cSCC Recurrence Risk if Tumor is Fully Excised
July 24th 2024

Deep Histological Margins Do Not Increase cSCC Recurrence Risk if Tumor is Fully Excised

© 2025 MJH Life Sciences

All rights reserved.